Placebocontrolled Preclinical Evaluation of Safety/Toxicology of induced pluripotent stem cells (iPSCs)-derived mesenchymal stem cells (MSCs) in clinically relevant ovine model of Severe Acute Lung Injury

Project: Other project

Project Details

StatusActive
Effective start/end date6/1/205/31/21

Funding

  • Citius Pharmaceuticals Inc: $324,317.00